{"id":"https://openalex.org/W2188790598","doi":null,"title":"COMPARATIVE STUDY REGARDING COMMERCIAL POLICIES FOR THE ROMANIAN ANTIDIABETICS' MARKET","display_name":"COMPARATIVE STUDY REGARDING COMMERCIAL POLICIES FOR THE ROMANIAN ANTIDIABETICS' MARKET","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2188790598","mag":"2188790598"},"language":"en","primary_location":{"id":"mag:2188790598","doi":null,"is_oa":false,"landing_page_url":"http://www.revistafarmacia.ro/20115/art.8.morgovan%20679-689.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2188790598"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022609577","display_name":"Claudiu Morgovan","orcid":"https://orcid.org/0000-0003-2730-8729","observed_orcids":["https://orcid.org/0000-0003-2730-8729"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudiu Morgovan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2730-8729","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003757599","display_name":"Smaranda Adina COSMA","orcid":"https://orcid.org/0000-0003-3875-9656","observed_orcids":["https://orcid.org/0000-0003-3875-9656"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Smaranda Cosma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3875-9656","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5052757627","display_name":"St\u00e9liana Ghibu","orcid":"https://orcid.org/0000-0003-2247-4613","observed_orcids":["https://orcid.org/0000-0003-2247-4613"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"St\u00e9liana Ghibu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2247-4613","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11161","display_name":"Consumer Market Behavior and Pricing","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/1406","display_name":"Marketing"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9200000166893005},{"id":"https://openalex.org/keywords/trade-policy","display_name":"trade policy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/pharmaceutical-marketing","display_name":"pharmaceutical marketing","score":0.6669999957084656},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.8169999718666077},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5339999794960022},{"id":"https://openalex.org/keywords/brand-attractiveness","display_name":"brand attractiveness","score":0.6710000038146973},{"id":"https://openalex.org/keywords/product-differentiation","display_name":"product differentiation","score":0.4830000102519989},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.5350000262260437},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C133925201","wikidata":"https://www.wikidata.org/wiki/Q188419","display_name":"Life expectancy","level":3,"score":0.7167861461639404},{"id":"https://openalex.org/C129400051","wikidata":"https://www.wikidata.org/wiki/Q7913","display_name":"Romanian","level":2,"score":0.63150954246521},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.5746840238571167},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5295354127883911},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48427480459213257},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4158974885940552},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.3949497938156128},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3488194942474365},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.19489416480064392},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1630832552909851},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.11243298649787903},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188790598","doi":null,"is_oa":false,"landing_page_url":"http://www.revistafarmacia.ro/20115/art.8.morgovan%20679-689.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1489628256","https://openalex.org/W1981003411","https://openalex.org/W2033442028","https://openalex.org/W2047588523","https://openalex.org/W2081276121","https://openalex.org/W2148798434","https://openalex.org/W2321912191"],"related_works":["https://openalex.org/W7001976226","https://openalex.org/W2623088170","https://openalex.org/W3197444747","https://openalex.org/W4404966052","https://openalex.org/W4415748394","https://openalex.org/W4399730504","https://openalex.org/W4413441284","https://openalex.org/W2801143351","https://openalex.org/W4386195754","https://openalex.org/W4415653379"],"abstract_inverted_index":{"The":[0],"success":[1],"of":[2,12,65,72,98,105,150,178],"the":[3,9,16,41,82,96,102,146,168,175],"marketing":[4],"activity":[5],"is":[6,29],"based":[7,52],"on":[8,15,20,40,140],"right":[10],"positioning":[11],"a":[13,30,49,134,162],"product":[14,141],"market":[17,170],"and":[18,37,43,62,77,87,143,148,188],"implicitly":[19],"its":[21],"differentiation":[22],"from":[23,174],"competing":[24],"products.":[25],"As":[26],"diabetes":[27],"mellitus":[28],"pathology":[31],"with":[32,44,117],"controversial":[33],"economic,":[34],"psychological,":[35],"social":[36],"medical":[38],"consequences":[39],"population":[42],"continuously":[45],"growing":[46],"prevalence,":[47],"providing":[48],"proper":[50],"drug":[51,157],"treatment":[53],"becomes":[54],"an":[55],"important":[56,172],"aspect":[57],"for":[58,81,136],"improving":[59],"life":[60,63],"quality":[61],"expectancy":[64],"diabetic":[66],"patients.":[67],"At":[68],"present,":[69],"several":[70,85],"classes":[71,114],"oral":[73,108,181],"antidiabetic":[74,156,182],"drugs":[75,183],"(OADs)":[76],"insulins":[78,122],"are":[79,93,184],"approved":[80],"Romanian":[83,169],"market,":[84],"molecules":[86],"numerous":[88],"original":[89],"or":[90],"generic":[91],"preparations":[92],"used":[94],"in":[95,115,125],"therapy":[97],"this":[99,106],"disease.":[100],"For":[101],"specific":[103],"purpose":[104],"paper,":[107,131],"medication":[109],"was":[110,158],"divided":[111],"into":[112],"three":[113],"relation":[116],"their":[118,186],"action":[119],"mechanism,":[120],"while":[121],"were":[123],"included":[124],"only":[126],"one":[127],"category.":[128],"In":[129],"our":[130],"we":[132,152],"allotted":[133],"score":[135],"each":[137],"brand,":[138],"depending":[139],"price":[142,187],"attractivity.":[144,166],"Following":[145],"survey":[147],"analysis":[149],"results,":[151],"found":[153],"that":[154],"no":[155],"perceived":[159],"as":[160],"having":[161],"higher":[163],"cost":[164],"than":[165],"On":[167],"some":[171],"products":[173],"commercial":[176],"point":[177],"view":[179],"among":[180],"registered,":[185],"attractivity":[189],"being":[190],"high:":[191],"NovoNorm":[192],"\u00ae":[193],"(repaglinide),":[194],"Glucobay":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2188790598","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":2}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}
